Nellis Air Force Base, NV1 Active Studies

Pulmonary Embolism Clinical Trials in Nellis Air Force Base, NV

Find 1 actively recruiting pulmonary embolism clinical trials in Nellis Air Force Base, NV. Connect with local research sites and explore new treatment options.

1
Active Trials
1
Sponsors
64
Enrolling

Recruiting Pulmonary Embolism Studies in Nellis Air Force Base

About Pulmonary Embolism Clinical Trials in Nellis Air Force Base

Pulmonary embolism (PE) is a blockage of an artery in the lungs, usually caused by blood clots that travel from the deep veins of the legs. It can be life-threatening and requires immediate medical attention. Treatment includes anticoagulants and in severe cases, thrombolytic therapy.

There are currently 1 pulmonary embolism clinical trials recruiting participants in Nellis Air Force Base, NV. These studies are seeking a combined 64 participants. Research is being sponsored by David Moss. Clinical trial participation is free and participants receive study-related medical care at no cost.

Pulmonary Embolism Clinical Trials in Nellis Air Force Base — FAQ

Are there pulmonary embolism clinical trials in Nellis Air Force Base?

Yes, there are 1 pulmonary embolism clinical trials currently recruiting in Nellis Air Force Base, NV. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Nellis Air Force Base?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Nellis Air Force Base research site will contact you about next steps.

Are clinical trials in Nellis Air Force Base free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Nellis Air Force Base studies also compensate for your time and travel.

What pulmonary embolism treatments are being tested?

The 1 active trials in Nellis Air Force Base are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary embolism.

Data updated July 13, 2026 from ClinicalTrials.gov